Entering text into the input field will update the search result below

Baudax Bio, Inc. (BXRX) CEO Gerri Henwood on Q1 2021 Results - Earnings Call Transcript

May 05, 2021 12:33 PM ETBaudax Bio, Inc. (BXRX)
SA Transcripts profile picture
SA Transcripts

Baudax Bio, Inc. (OTC:BXRX) Q1 2021 Results Earnings Conference Call May 5, 2021 8:00 AM ET

Company Participants

Claudia Styslinger - Investor Relations

Gerri Henwood - President and Chief Executive Officer

Richard Casten - Chief Financial Officer

Conference Call Participants

Leland Gershell - Oppenheimer


Good morning and welcome to the Baudax Bio First quarter 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will be given at that time. As a reminder, this conference is being recorded at the company’s request.

I would now like to turn the call over to Claudia Styslinger, Investor Relations. You may begin.

Claudia Styslinger

Good morning and thank you for joining us on today’s conference call to discuss Baudax Bio’s first quarter 2021 financial results. This is Claudia Styslinger and I am joined today by Gerri Henwood, President and Chief Executive Officer; and Rick Casten, Chief Financial Officer. On today’s call, Gerri will begin by providing some introductory remarks, Rick will then discuss the financial highlights from the quarter and Gerri will with a business update and discuss the continued progress around the commercialization of ANJESO.

Earlier this morning, we issued a press release detailing our financial results for the first quarter 2021. The press release along with the slide presentation that we will reference for today’s call is available on the events page of the News and Investors section of our website at baudaxbio.com. Please note, the slides for today’s presentation are viewer controlled.

Before we begin our formal comments, I will remind you that various remarks we make today constitute forward-looking statements pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements related to our financial outlook. These forward-looking statements are subject

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

About BXRX

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on BXRX

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.